Lydia Koi

530 total citations
19 papers, 375 citations indexed

About

Lydia Koi is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology. According to data from OpenAlex, Lydia Koi has authored 19 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 9 papers in Cancer Research and 7 papers in Molecular Biology. Recurrent topics in Lydia Koi's work include Cancer, Hypoxia, and Metabolism (9 papers), Lung Cancer Treatments and Mutations (5 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Lydia Koi is often cited by papers focused on Cancer, Hypoxia, and Metabolism (9 papers), Lung Cancer Treatments and Mutations (5 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Lydia Koi collaborates with scholars based in Germany, Netherlands and United States. Lydia Koi's co-authors include Michaël Baumann, Mechthild Krause, Daniel Zips, Kristin Gurtner, Kerstin Brüchner, Ina Kurth, Anna Dubrovska, Claudia Peitzsch, Ala Yaromina and Monica Cojoc and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, International Journal of Cancer and Oncotarget.

In The Last Decade

Lydia Koi

19 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lydia Koi Germany 10 154 150 144 112 84 19 375
Julian Mangesius Austria 9 89 0.6× 70 0.5× 84 0.6× 88 0.8× 78 0.9× 23 287
Monique C. de Jong Netherlands 11 191 1.2× 175 1.2× 159 1.1× 105 0.9× 60 0.7× 13 443
Goutham Hassan Venkatesh United Arab Emirates 12 237 1.5× 253 1.7× 190 1.3× 132 1.2× 84 1.0× 18 533
Huan-Huan Wang China 11 158 1.0× 100 0.7× 195 1.4× 151 1.3× 48 0.6× 13 461
Go Oshima United States 7 113 0.7× 146 1.0× 181 1.3× 174 1.6× 54 0.6× 13 418
Janet Taylor United Kingdom 7 259 1.7× 304 2.0× 100 0.7× 125 1.1× 69 0.8× 10 505
Sara Grehl Germany 9 178 1.2× 120 0.8× 110 0.8× 181 1.6× 187 2.2× 10 429
Willem DuBois United States 6 105 0.7× 114 0.8× 141 1.0× 129 1.2× 126 1.5× 7 373
Robert Konschak Germany 9 120 0.8× 189 1.3× 241 1.7× 102 0.9× 26 0.3× 12 397
Turi Danielsen Norway 10 160 1.0× 174 1.2× 109 0.8× 40 0.4× 69 0.8× 11 367

Countries citing papers authored by Lydia Koi

Since Specialization
Citations

This map shows the geographic impact of Lydia Koi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lydia Koi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lydia Koi more than expected).

Fields of papers citing papers by Lydia Koi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lydia Koi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lydia Koi. The network helps show where Lydia Koi may publish in the future.

Co-authorship network of co-authors of Lydia Koi

This figure shows the co-authorship network connecting the top 25 collaborators of Lydia Koi. A scholar is included among the top collaborators of Lydia Koi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lydia Koi. Lydia Koi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Koi, Lydia, Mahnaz Bonrouhi, Annett Linge, et al.. (2024). Transcriptomic and epigenetic landscape of nimorazole-enhanced radiochemotherapy in head and neck cancer. Radiotherapy and Oncology. 199. 110348–110348. 3 indexed citations
3.
Yaromina, Ala, et al.. (2023). Overcoming radioresistance with the hypoxia-activated prodrug CP-506: A pre-clinical study of local tumour control probability. Radiotherapy and Oncology. 186. 109738–109738. 7 indexed citations
4.
Koi, Lydia, Annett Linge, Steffen Löck, et al.. (2023). Prognostic biomarkers for the response to the radiosensitizer nimorazole combined with RCTx: a pre-clinical trial in HNSCC xenografts. Journal of Translational Medicine. 21(1). 576–576. 6 indexed citations
5.
Koi, Lydia, Michaël Baumann, Mechthild Krause, et al.. (2021). Tyrosine Kinase c-MET as Therapeutic Target for Radiosensitization of Head and Neck Squamous Cell Carcinomas. Cancers. 13(8). 1865–1865. 13 indexed citations
6.
Koi, Lydia, J. Müller, Robert Freudenberg, et al.. (2021). Molecular Response to Combined Molecular- and External Radiotherapy in Head and Neck Squamous Cell Carcinoma (HNSCC). Cancers. 13(22). 5595–5595. 2 indexed citations
8.
Dietrich, Antje, Michael Andreeff, Lydia Koi, et al.. (2020). Radiotherapy enhances uptake and efficacy of 90Y-cetuximab: A preclinical trial. Radiotherapy and Oncology. 155. 285–292. 12 indexed citations
9.
Gurtner, Kristin, Lydia Koi, Cyril H. Benes, et al.. (2019). Radioresistance of KRAS/TP53‐mutated lung cancer can be overcome by radiation dose escalation or EGFR tyrosine kinase inhibition in vivo. International Journal of Cancer. 147(2). 472–477. 39 indexed citations
10.
Koi, Lydia, Steffen Löck, Annett Linge, et al.. (2017). EGFR-amplification plus gene expression profiling predicts response to combined radiotherapy with EGFR-inhibition: A preclinical trial in 10 HNSCC-tumour-xenograft models. Radiotherapy and Oncology. 124(3). 496–503. 14 indexed citations
11.
Koi, Lydia, et al.. (2017). The HIV protease and PI3K/Akt inhibitor nelfinavir does not improve the curative effect of fractionated irradiation in PC-3 prostate cancer in vitro and in vivo. Clinical and Translational Radiation Oncology. 2. 7–12. 7 indexed citations
12.
Troost, Esther G.C., Lydia Koi, Ala Yaromina, & Mechthild Krause. (2017). Therapeutic options to overcome tumor hypoxia in radiation oncology. Clinical and Translational Imaging. 5(5). 455–464. 4 indexed citations
13.
Koi, Lydia, Christoph Weise, Christine A. Erdmann, et al.. (2016). OC-0130: Biomarker-based hypoxia-adapted radiochemotherapy: preclinical study in HPV+/- H&N cancer xenografts. Radiotherapy and Oncology. 119. S59–S59. 1 indexed citations
14.
Dietrich, Antje, Lydia Koi, Klaus Zöphel, et al.. (2015). Improving external beam radiotherapy by combination with internal irradiation. British Journal of Radiology. 88(1051). 20150042–20150042. 26 indexed citations
15.
Kurth, Ina, Katrin Mäbert, Claudia Peitzsch, et al.. (2015). Cancer stem cell related markers of radioresistance in head and neck squamous cell carcinoma. Oncotarget. 6(33). 34494–34509. 86 indexed citations
17.
Koi, Lydia, Ralf Bergmann, Kerstin Brüchner, et al.. (2014). Radiolabeled anti-EGFR-antibody improves local tumor control after external beam radiotherapy and offers theragnostic potential. Radiotherapy and Oncology. 110(2). 362–369. 46 indexed citations
18.
Koi, Lydia, Kerstin Brüchner, Kristin Gurtner, et al.. (2013). Hypoxia-Inducible Factor Pathway Inhibition Resolves Tumor Hypoxia and Improves Local Tumor Control After Single-Dose Irradiation. International Journal of Radiation Oncology*Biology*Physics. 88(1). 159–166. 29 indexed citations
19.
Yaromina, Ala, et al.. (2012). Prognostic value of HIF-1α expression during fractionated irradiation. Strahlentherapie und Onkologie. 188(11). 1031–1037. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026